Ensure Maximum Deal Value & Streamlined Operations
In today’s M&A-heavy life sciences climate, the role that IT plays in integration and divestiture planning in both the short- and long-term success of a deal cannot be overstated.
From helping small firms audit their systems in advance of activity to assisting Tier 1 clients in crafting and executing upon their post-transaction integration strategy, our team has rich experience across the entire deal spectrum.
Results-Focused M&A IT Consulting
Technology plays a role in every aspect of the life sciences M&A process, starting long before a deal is finalized. Unlocking maximum deal value requires an experienced hand who can advise on strategy, best practices and feasibility, and execute like a member of the team. No matter our clients’ role in the transaction, our goal is simple: Optimize IT systems and processes to deliver maximum financial and operational returns.
Mergers, Acquisitions & Divestitures Services
Daelight has helped pharmaceutical, biotech and medical device firms of all sizes:
- Swiftly understand opportunities and risks during due diligence
- Ready themselves for acquisition by assessing and shoring up technology systems
- Effectively and efficiently integrate systems in a compliant manner post-transaction
- Carve out business lines or units for divestiture
Our M&A playbook is unique among life sciences IT consultants. We offer end-to-end service for any party, from initial planning and conceptualization through project management and execution. Our clients get highly experienced consultants from Day 1 through project completion; there’s no “bait and switch” via subcontracting or assigning unvetted resources. Regardless of the project size or scope, we’re there as part of the team until the results show.